Source:http://linkedlifedata.com/resource/pubmed/id/20837340
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-9-14
|
pubmed:abstractText |
Donor killer cell immunoglobulin-like receptor (KIR) ligand incompatibility in the graft-versus-host direction is associated with decreased relapse incidence and improved disease-free survival after haploidentical and human leucocyte antigen (HLA)-mismatched unrelated, haematopoietic stem cell transplantation. However, review of all published studies of allogeneic HLA-matched or mismatched stem cell transplantation shows that the results on the relationship between donor-recipient KIR(-ligand) (in)compatibility and outcomes are highly variable, ranging from highly beneficial to detrimental. Reasons for these differences may include the methodology to determine KIR(-ligand) incompatibility, the disease distribution and the transplant protocol or donor type. Two retrospective studies on the effects of KIR-ligand incompatibility in unrelated cord blood transplantation (UCBT) for haematological malignancies have resulted in conflicting results. The Eurocord study showed a favourable effect of KIR-ligand mismatching on relapse incidence and leukaemia-free survival, whereas the Minneapolis study showed no effect on these end points and a detrimental effect on incidence of graft-versus-host disease (GvHD). In patients with non-malignant disorders, KIR-ligand (in)compatibility between donor and recipient was not associated with outcomes in a recent Eurocord analysis. Therefore, the role of natural killer (NK) cell alloreactivity in UCBT is far from clear. It is too early to use a donor-recipient KIR(-ligand) algorithm for selection of a cord blood donor.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1532-1924
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
283-90
|
pubmed:meshHeading |
pubmed-meshheading:20837340-Cord Blood Stem Cell Transplantation,
pubmed-meshheading:20837340-Disease-Free Survival,
pubmed-meshheading:20837340-Graft vs Host Disease,
pubmed-meshheading:20837340-HLA Antigens,
pubmed-meshheading:20837340-Histocompatibility,
pubmed-meshheading:20837340-Histocompatibility Testing,
pubmed-meshheading:20837340-Humans,
pubmed-meshheading:20837340-Incidence,
pubmed-meshheading:20837340-Leukemia,
pubmed-meshheading:20837340-Ligands,
pubmed-meshheading:20837340-Receptors, KIR,
pubmed-meshheading:20837340-Survival Rate,
pubmed-meshheading:20837340-Tissue Donors,
pubmed-meshheading:20837340-Transplantation, Homologous
|
pubmed:year |
2010
|
pubmed:articleTitle |
Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
|
pubmed:affiliation |
Department of Hematology, Leiden University Medical Center, the Netherlands. R.Willemze@lumc.nl
|
pubmed:publicationType |
Journal Article,
Review
|